References
- Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol. 2009. 81: 529-535. https://doi.org/10.1002/jmv.21347
- Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer. 2008. 18: 71-79
- Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Munoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008. Suppl 10: K1-16.
- Bosch FX, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr. 2003. 31: 3-13.
- Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009. 10: 321-322. https://doi.org/10.1016/S1470-2045(09)70096-8
- Ding X, Liu Z, Su J, Yan D, Sun W, Zeng Z. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing. J Med Virol. 2014. 86: 1937-1943. https://doi.org/10.1002/jmv.24044
- Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007. 297: 813-819. https://doi.org/10.1001/jama.297.8.813
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010. 127: 2893-2917. https://doi.org/10.1002/ijc.25516
- Hu SY, Hong Y, Zhao FH, Lewkowitz AK, Chen F, Zhang WH, Pan QJ, Zhang X, Fei C, Li H, Qiao YL. Prevalence of HPV infection and cervical intraepithelial neoplasia and attitudes towards HPV vaccination among Chinese women aged 18-25 in Jiangsu province. Chin J Cancer Res. 2011. 23: 25-32. https://doi.org/10.1007/s11670-011-0025-3
-
Kim S, Lee D, Park S, Kim TU, Jeon BY, Park KH, Lee H. REBA HPV-ID
$^{(R)}$ for efficient genotyping of human papillomavirus in clinical samples from Korean patients. J Med Virol. 2012a. 84: 1248-1253. https://doi.org/10.1002/jmv.23334 - Kim S, Lee D, Kim Y, Kim G, Park S, Choi Y, Kim TU, Park KW, Lee H. Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer. J Exp Biomed Sci. 2012b. 18: 123-130.
- Liu XX, Fan XL, Yu YP, Ji L, Yan J, Sun AH. Human papillomavirus prevalence and type-distribution among women in Zhejiang province, southeast china: across-sectional study. BMC Infectious Diseases. 2014. 14: 708-714. https://doi.org/10.1186/s12879-014-0708-8
- Okadome M1, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2. J Obstet Gynaecol Res. 2014. 40: 561-569. https://doi.org/10.1111/jog.12202
- Sun B, He J, Chen X, He M, He Z, Wang Y, Shang Q, Yu L, Wei L. Prevalence and genotype distribution of human papillomavirus infection in harbin, Northeast China. Arch Virol. 2014. 159: 1027-1032. https://doi.org/10.1007/s00705-013-1886-1
- Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012. 131: 2929-2938. https://doi.org/10.1002/ijc.27571